MALAT1 and hepatocellular carcinoma: In the current study, a novel genetic variant, viz., rs1194338, in the promoter region of MALAT1 was evaluated, and we found that female HCC patients with the MALAT1 rs1194338 A allele were significantly associated with a decreased risk of developing vascular invasion compared to those with the C allele.